Retractable Technologies trims workforce by 7% as tariff concerns loom
Retractable Technologies is laying off around 7% of its workforce to free up resources amid market uncertainty prompted by the Trump administration’s tariffs. The US-based developer of retractable needles and insulin syringes expects to save around $1.6m …